Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US CBD Supplement Market Anxious For Lawful Use Proposal, And FDA Offers Cannabis Drug Research Guidance

Jul 23 2020

• By Malcolm Spicer

ApplesOranges

Related Content

FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements

Dec 28 2018

US FDA Reopens Door For CBD Safety Data, But NPA Says Window Closing For Setting Safe Level

Mar 10 2020

‘Time Is Now’ For FDA Rule On Lawful CBD Use In Supplements, CRN Says In Citizen Petition

Jun 17 2020

New Report, Same Theme On US FDA's Policy On Cannabidiols: ‘Extensive Data Gaps’ On Safety

Jul 10 2020

HBW Market News: CHPA Petitions For CBD Reg, PEW Urges Stronger Supplement Oversight

Nov 15 2019

Drug Innovation Needs Exclusivity For Some Natural Substances, PhRMA Recommends

Jul 25 2019

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

Additional Topics

International United States US States Dietary Supplements Cannabidiol CBD Guidance Documents Advertising, Marketing & Sales Business Strategies Clinical Trials Compliance Commercial Drug Approval Standards FDA Ingredients Manufacturing Policy Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window